IGMS logo

IGM Biosciences, Inc. Stock Price

NasdaqGS:IGMS Community·US$76.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

IGMS Share Price Performance

US$1.27
-0.73 (-36.50%)
US$1.27
-0.73 (-36.50%)
Price US$1.27

IGMS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
0 Rewards

IGM Biosciences, Inc. Key Details

US$145.1m

Revenue

US$150.5m

Cost of Revenue

-US$5.5m

Gross Profit

US$47.9m

Other Expenses

-US$53.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.89
-3.79%
-36.80%
0%
View Full Analysis

About IGMS

Founded
1993
Employees
16
CEO
Mary Harler
WebsiteView website
igmbio.com

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

Recent IGMS News & Updates

Recent updates

No updates